The president and chief operating officer of Quintiles, John Ratliff, is departing the world’s largest pharmaceutical services company at the end of December after a nine-year run.
Quintiles spokesman Phil Bridges said Ratliff’s resignation, announced Thursday morning, was “a personal decision for John, and Quintiles wishes him well.” Bridges also said that Ratliff wasn’t available to comment on his decision or his future plans.
Ratliff joined Quintiles as chief financial officer in 2004 and was named COO in 2006. He was named president in August 2010. Ratliff also has been a member of Quintiles’ board of directors since 2006; he’s retiring from that role as well.
Tom Pike, CEO of the Durham-based company, addressed Ratliff’s departure during the company’s third-quarter earnings conference call with analysts.
“Over the decade we were private, John provided great leadership,” Pike said. “John has also been a great partner to me.” Quintiles went public in May.
Pike also expressed confidence that the management transition will be a smooth one.
“Quintiles has a strong global executive team,” he said. “I believe it’s the best in the business.”
“I’m confident,” he added, “in the ability of our deep management team to continue to execute on our day-to-day operational delivery needs while also innovating to deliver value to our customers.”
Quintiles’ announcement included a statement from Ratliff talking about the “tremendous experience” he has had at Quintiles.
“The difference this company has made in people’s lives is truly amazing, and I am extremely proud to played a part in it,” Ratliff said. “I love Quintiles and wish the best of luck to the entire organization.”